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Keratolytic winter erythema (KWE), also known as Oudtshoorn skin disease, is characterised by a cyclical disruption of normal epidermal 
keratinisation affecting primarily the palmoplantar skin with peeling of the palms and soles, which is worse in the winter. It is a rare 
monogenic, autosomal dominant condition of unknown cause. However, due to a founder effect, it occurs at a prevalence of 1/7  200 
among South African Afrikaans-speakers. In the mid-1980s, samples were collected from affected families for a linkage study to pinpoint 
the location of the KWE gene. A genome-wide linkage analysis, using microsatellite markers, identified the KWE critical region on 
chromosome 8p23.1-p22. Subsequent genetic studies focused on screening candidate genes in this critical region; however, no pathogenic 
mutations that segregated exclusively with KWE were identified. The cathepsin B (CTSB) and farnesyl-diphosphate farnesyltransferase 1 
(FDFT1) genes revealed no potentially pathogenic variants, nor did they show differential gene expression in affected skin. Mutation 
detection in additional candidate genes also failed to identify the KWE-associated variant, suggesting that the causal variant may be in an 
uncharacterised functional region. Bioinformatic analysis revealed highly conserved regions within the KWE critical region and a custom 
tiling array was designed to cover this region and to search for copy number variation. Although the study did not identify a variant that 
segregates exclusively with KWE, it provided valuable insight into the complex KWE-linked region. Next-generation sequencing approaches 
are being used to comb the region, but the causal variant for this interesting hyperkeratotic palmoplantar phenotype still remains elusive. 
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Dermatologists in South Africa (SA) have long been 
aware of a novel inherited skin disease, which was 
prevalent in families originating in the Oudtshoorn 
district of the Eastern Cape. In 1977, a meeting 
hosted by Professor Trefor Jenkins was held in 
Johannesburg. Based on the discussions and in collaboration with 
other dermatologists in SA, George Findlay authored the first 
publication detailing the clinical features and naming this novel 
genodermatosis, keratolytic winter erythema (KWE) or Oudtshoorn 
skin.[1] He later added the latinised variation, erythrokeratolysis 
hiemalis.[2] Trefor Jenkins guided the extensive genealogical work 
by his PhD student, Peter Hull, who demonstrated that families 
with KWE residing in both the Oudtshoorn and Genadendal 
districts could be traced back to a single founder individual born in 
France. For several decades, scientists and students in the Division 
of Human Genetics, University of the Witwatersrand (Wits), and 
their collaborators have been searching for the mutation which is 
responsible for this fascinating skin disorder (Fig.  1).[1,3-9] This is a 
brief overview of the search which also includes some novel data 
exploring the genomic architecture of the region where the causal 
mutation resides. 
Clinical features
The most constant clinical sign of KWE is a cyclical, centrifugal 
peeling of the skin of the palms and soles.[1,3] None of the other 
features of the disorder have been observed as isolated findings in the 
absence of this hand and foot involvement. In general, these changes 
are worse in the winter or with the changing of the seasons. In the 
mildest cases the only clinical evidence is scaling and redness of the 
web spaces of the fingers and toes. In some cases, there is a well-
demarcated red boundary at the upper edge to the sole, or erythema 
may be observed which often involves the entire palm or sole. The 
initial clinical sign is the formation of superficial dry bullae that may 
be localised and well defined, or alternatively the skin appears opaque 
prior to it dissecting off to form a firm elastic peel. The peeling may 
occur at multiple sites, but rarely a single large ‘bulla’ may form a peel 
that involves the entire palm. The peeling proceeds centrifugally and 
is only arrested at major skin creases where a mild hyperkeratosis 
may persist for several weeks. The base revealed under the peeling 
skin is again red, while the papillary ridge pattern is retained (Fig. 2). 
After a variable period of time, ranging from days to weeks, the cycle 
repeats itself. Hyperhidrosis is common during both the summer 
and winter and the sweat is often described as having a distinctive 
odour, which may be no more than the stench of macerated keratin. 
Although the palms and soles are most frequently affected, in some 
cases an annular erythema is noted involving the dorsum of the hands 
and forearms as well as the lower extremities including the buttocks. 
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Fig. 1. Chronology of the research progress on searching for the keratolytic winter erythema (KWE)-causing mutation in South African families, showing the 
key contributions and publications over more than 4 decades. Although first formally described in 1977, the KWE causing founder mutation in South African 
families remains elusive. cDNA = complementary DNA.[1,3-9]
Fig. 2. Palm showing mild erythema and extensive peeling.
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The trunk is only very rarely affected. These annular or rosette-like 
lesions have an outer expanding edge with a trailing circinate peel and 
central lamellar scale. They may expand over a period of 4 - 6 weeks 
reaching up to 15 mm in size before healing. The condition improves 
with age and in adulthood only minimal scaling may be noted that is 
confined to the creases.
Histopathology
The changes are dynamic and are best illustrated by examining 
the annular lesions (Fig.  3). The earliest change appears be a 
focal area of mild spongiosis that spreads centrifugally. The 
affected keratinocytes fail to undergo normal keratinisation and are 
pushed upwards to form a compact parakeratotic layer beneath the 
previously normal orthokeratotic stratum corneum. There is rapid 
recovery of the epidermis and this is associated with a proliferation 
of basal keratinocytes and restoration of a granular layer and 
orthokeratotic horny layer. The parakeratotic scale then appears 
sandwiched between the original normal orthokeratotic layer and 
the newly regenerated orthokeratotic stratum corneum. The split 
occurs above the newly formed stratum corneum and forms a 
substantial peel.[1]
Electron microscopy
Only the annular rosette-like lesions have been examined. The 
spongiotic areas were extremely focal and found in the periphery 
of the erythema. They were characterised by greatly expanded 
intercellular spaces. The desmosomes occupied a central position 
in the interspace with taut, thin cytoplasmic strands connecting 
them to the opposing cells. Where the intercellular space was grossly 
expanded, the desmosomes appeared to be floating freely within 
the intercellular space without such connections. The desmosomes 
were morphologically normal and did not show internal separation. 
Apoptotic bodies rich in tonofilaments were not found. The internal 
structure of the keratinocytes showed striking changes in the 
mitochondria, including intracristal swelling with ballooning of 
the cristae and a denser matrix. Some of the keratinocytes showed 
larger electron lucid vacuoles that were arranged in a perinuclear 
position and these vacuoles appeared to develop from the progressive 
degeneration of the mitochondria.[3]
Genetic studies
KWE is an autosomal dominant, monogenic disorder with high 
penetrance. Families with KWE have been described mostly from 
SA where a genealogical study has identified a common ancestor 
and presumed founder, Captain Francois Renier Duminy, who was 
born in Lorient in France in 1747.[3] He was a mariner and visited 
the Cape of Good Hope several times, and later settled there with 
his wife, Johanna Margaretha (née Nöthling). A large German family 
with KWE has been described and two possible sporadic cases, one 
from Germany and the other from Denmark have been reported. [10,11] 
Interestingly, there are no reported cases of KWE from France and 
it is possible that a different diagnosis may be attributed to the 
phenotype, which is likely to be quite rare. 
The first sample collections for DNA studies in the KWE families 
started in the mid-1980s when several field trips were organised to 
the Oudtshoorn and Genadendal districts. 
Genetic linkage
In the mid-1990s, a collaboration was initiated with Andre Reis’ 
group from Germany to perform a genome-wide linkage study 
using microsatellite markers. Michelle Starfield, an MSc student 
in the Division of Human Genetics, the SA Institute for Medical 
Research (SAIMR) and Wits, embarked on research visits to the 
German laboratory which culminated in the identification of linkage 
to markers on chromosome 8p22-p23 in both the SA families and 
in the large German kindred.[4] Haplotype analysis in the SA KWE 
families supported a common ancestry, while the German family 
demonstrated a different haplotype, suggesting a different origin. 
Based on these data and subsequent linkage analysis, attempting to 
narrow down the region of the KWE mutation, it was concluded that 
it is likely that through their single founder, all affected individuals in 
SA would have the same mutation.
Candidate genes
Once the KWE region had been mapped, it was important to identify 
candidate genes in the KWE critical region. Anton Bergheim, a PhD 
student at the SAIMR and Wits, and Silke Appel from Germany, used 
bacterial artificial chromosome (BAC) contigs of chromosome 8p22-
p23 and exome capture to select transcripts from this region. Twelve 
transcripts were identified by exon trapping, complementary DNA 
(cDNA) selection and sequence analyses, but no pathogenic mutations 
were identified in any of these transcripts.[7] Further analysis of 16 
candidate cDNA clones derived from this experiment was performed 
by Hugh Napier, an MSc student (unpublished data) but yielded no 
candidate mutations. In an attempt to narrow down the KWE region and 
pinpoint the causative gene more precisely, families with informative 
crossover events were investigated. As a result, the KWE critical area 
was narrowed to chromosome 8p23.1-p22 between, and including 
markers D8S1759 and D8S552, a region roughly1.26 Mb in size. The 
KWE critical region is flanked by two olfactory receptor/defensin 
repeat regions which are prone to non-homologous recombination 
resulting in large chromosomal rearrangements, including a common 
4.7 Mb polymorphic 8p23 inversion.[12]
Candidate gene analysis and gene expression
The two genes identified within the KWE critical region as being the 
most likely candidates, based not only on chromosomal location but 
also on biological function, were the cathepsin B (CTSB) gene and the 
farnesyl-diphosphate farnesyltransferase 1 (FDFT1) gene. Mutation 
Fig. 3. Biopsy from the sole of the foot showing a recovered granular layer 
and a layer of parakeratosis sandwiched between the old orthokeratotic 
stratum corneum and a re-established orthokeratotic layer.
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screening of the coding regions, 5’ untranslated regions (UTRs) and 
intron/exon boundaries of both genes in genomic DNA and cDNA 
of patients affected with KWE identified no causal variants. To 
determine whether these genes had differential expression in KWE-
affected individuals compared with unaffected controls, epidermal 
skin biopsies were taken from either the individuals’ palms or soles. 
RNA was extracted from the skin samples and reverse-transcribed 
into cDNA, which was used as the template in quantitative real-time 
polymerase chain reaction analysis. The comparative ∆∆Ct method 
was used to determine the target genes’ relative expression in affected 
individuals. A marked increase in the expression of FDFT1 messenger 
RNA (mRNA) was observed in affected individuals. However, this 
increase was not statistically significant in the small sample size tested, 
although increased expression of the gene appeared to be correlated 
with the severity of the clinical presentation. An examination of the 
FDFT1 promoter failed to identify a KWE-restricted variant.[9]
Novel data exploring highly conserved coding and non-
coding regions and copy number variants 
As the examination of candidate genes in the critical region failed to 
identify KWE-associated variants, the possibility of the causal variant 
occurring in an uncharacterised functional region was investigated. 
Although variants within protein-coding genes are more likely to 
be implicated as disease-causing mutations, highly conserved, non-
protein-coding regions have been shown to be involved in gene 
regulation. Variations within these regions may directly affect the 
expression levels of nearby genes and be involved in the cause of 
diseases.[13] In addition to the presence of genetic variation in the 
form of microscopically visible chromosomal rearrangements and 
single nucleotide changes, there is an abundance of copy number 
variations (CNVs) of DNA segments throughout the genome. CNVs 
have been implicated as the cause of a number of genetic disorders[14,15] 
and many CNV regions have been observed on chromosome 8p23.1 
within the region of the β-defensin gene cluster. [16,17] A two-fold 
approach was aimed at examining the critical region for both highly 
conserved coding and non-coding sequences as well as CNVs and 
to characterise these regions further to determine if they may be 
functional and play a role in the molecular aetiology of KWE. This 
work was the research of an MSc student, Shaun Aron.[8]
Bioinformatic analysis of novel 
regions of interest
To identify previously uncharacterised functional sequences within 
the KWE critical region, a comparative genomics approach was used 
to identify regions that exhibited high levels of conservation across 
a range of evolutionarily diverse organisms. A multiple sequence 
alignment of the critical region on chromosome 8:11 317 148 - 12 899 
353 (HG18) for eight evolutionarily diverse organisms was generated. 
Regions ≥100  bp that showed a conservation score of >70% were 
identified and further characterised for functional signatures via in 
silico prediction methods for gene structures, transcription factor 
binding sites and RNA secondary structures. 
Eight distinct regions of high conservation were identified. Six 
were found within non-coding regions of the genome, while the 
remaining two were within a previously annotated open reading 
frame. Each of these regions ranged in size from 100 bp to 406 bp 
and showed high levels of conservation in at least six of the species. 
Of the eight regions assessed for potential functional roles, only one 
presented as a possible functional candidate for KWE. The region was 
highly conserved across all eight species and presented as a possible 
single-exon gene structure. Further examination revealed that there 
was an exact match of the region to an mRNA sequence previously 
described as Homo sapiens deubiquitinating enzyme 3 (DUB3). At the 
time of the study, DUB3 was not mapped to chromosome 8; however, 
it was known to belong to a group of deubiquitinating enzymes 
responsible for the cleavage of ubiquitin-conjugated proteins. 
Deubiquitinating enzymes function by removing the covalently 
attached ubiquitin from proteins, thereby controlling substrate 
activity and/or abundance. DUB3 is a cytokine inducible protein 
expressed transiently and is thought to play a role in blocking cell 
proliferation and inducing apoptosis through the ubiquitin pathway. 
The molecular functioning of DUB3 therefore presented the gene as 
a likely novel candidate gene for the KWE phenotype. Subsequently, 
during the period of the study, DUB3 was annotated to this conserved 
region as a single exon gene lacking a 5’ or 3’ UTR and encoding a 
protein of 530 amino acids. This annotation correlated perfectly with 
the gene prediction obtained in the study. The gene was sequenced in 
a subset of KWE-affected individuals to identify a possible mutation 
within the coding region; however, all six of the variants identified 
were observed at a frequency of >70% in a corresponding control 
group and therefore unlikely to be causal. 
Copy number variation
A custom tiling array (Roche NimbleGen) containing roughly 
385  000 probes at a resolution of 11  bp was designed based on an 
extended region encompassing the inverted region on chromosome 
8p and the KWE-linked critical region between markers D8S1759 
and D8S552 (chromosome 8: 11 415 050 - 12 886 829 (HG18)). 
Samples were collected from 10 individuals from four families of 
which five were KWE-affected and five were unaffected.
The comparative genome array data were normalised using the 
Qspline method and two datasets were generated for further analysis. 
The first was the complete normalised dataset consisting of 384 702 
data points and the second was a transformed window-averaged 
dataset generated by averaging the intensities across 100 bp windows 
to analyse larger regions of CNV. All known protein-coding genes 
in the region were examined for CNVs in both the KWE-affected 
and unaffected samples. To compare the CNVs between the affected 
and unaffected individuals, a pairwise comparison was conducted 
between the affected individual and their unaffected relative. CNVs 
that were present in both the affected and unaffected individuals were 
excluded since they are unlikely to be involved in KWE. All regions 
that exhibited CNV only in the affected individuals were further 
assessed to determine if they might play a role in the molecular 
aetiology of KWE.
None of the previously studied candidate genes showed CNV. The 
regions that exhibited CNVs either occurred within known low-copy 
repeat regions, i.e. β-defensin and olfactory receptor gene clusters or 
within genes outside of the KWE critical region. Although higher 
copy numbers of the repeat unit encompassing the β-defensin cluster 
has been implicated in inflammatory skin disorders such as psoriasis, 
no consistent CNV at this region was observed across all five KWE 
affected individuals. The genes found outside of the KWE region 
that showed CNV included MSRA, RP1L1, PINX1 and XKR6. These 
genes were further investigated, but their molecular function failed to 
suggest any link to the pathogenesis of KWE.
A number of smaller CNVs were identified within non-coding 
regions. Two of the most plausible CNVs, possibly involved in a 
position effect were those identified upstream of the two strong KWE 
candidate genes, CTSB and DUB3 (USP17L2). The CNV upstream of 
CTSB is located 8 873 bp upstream of the gene and was found to be 
duplicated in 3/5 affected individuals with no variation observed in 
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the control samples. It is possible that this region may harbour some 
regulatory elements involved in the control of expression of either 
CTSB or another gene in the region. Similarly, the CNV of 24  bp 
found 38 007 bp upstream of DUB3, which was deleted in 3/5 affected 
individuals could possibly be involved in the regulation of DUB3. 
Most disease causing CNVs involving regulatory regions encompass 
large regions of regulatory sequences ranging in size from kb to Mb. 
It is therefore unlikely that these regions alone would be involved in 
the molecular aetiology of KWE, but they do present as interesting 
areas for further investigation. 
Although the study did not identify the causal variant for KWE, it 
served as an exploratory method to provide valuable insight into the 
complex KWE-linked region and provide potential regions of interest 
for further study. 
Treatment
The results of treatment are disappointing and highly variable. Topical 
steroids seem to be helpful in some cases, but in others appear to 
aggravate the condition. In one patient, systemic steroids temporally 
resolved the annular lesions. Most promising has been the work by 
Amin et al.,[18] reporting on the use of photodynamic therapy (PDT) 
for the treatment of systematic KWE. Methyl 5- aminolevulinate was 
used as the photosensitiser and only two treatments were given, one 
week apart. The patch was exposed to 37 J/cm2 with 630 nm red light, 
3 hours after the application of the photosensitiser. The treated area 
remained disease-free at 24 months. Certain features of KWE lesions, 
such as a defect in the stratum corneum and an increased rate of cell 
proliferation, may explain the success of PDT as a possible treatment 
for the disease. These features could lead to the selective uptake of 
the photosensitiser into abnormal cells. PDT may be a successful 
treatment for KWE, but is yet to be widely tested.[18]
Next steps
The mutation responsible for KWE remains elusive. The phenotype 
presents periodically, with some clinical differences at different 
time points of a life and across individuals, its effects appear to 
be modulated by environmental and physiological factors such 
as cooler temperature, systemic infection and pregnancy, and the 
cellular phenotype is propagated from cell to cell, possibly via gap 
junctions. Many avenues to the identification of the KWE mutation 
have been explored including candidate gene mutation detection, 
gene expression changes, the identification of conserved regions in 
the KWE critical region and CNV regions; yet none has pinpointed 
a mutation restricted to affected individuals. New technologies are 
presenting novel high-throughput biological approaches including 
target genome capture and next-generation sequencing and extensive 
quantitative transcriptome analysis. Challenges remain in identifying 
which genetic variants are potentially causal and in isolating relevant 
cells at appropriate stages of pathology for detailed transcriptome 
research. Although there is still no effective treatment, photodynamic 
therapy has a disease-modifying effect, but needs to be better 
understood. KWE remains a genetic and molecular riddle to be 
solved.
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